2Macaya C, Serruys PW, Ruygrok P, et al. Continued benefit of coronary stenting versus balloon angioplasty:one year clinical follow up of BEN- ESENT trial [ J ]. J Am Cardiol, 1996,27 (2) :255 - 261.
3Mehran R, Dangas G, Abizaid AS, et al. Angiographic patterns of in- stent restenosis: classification and implications for long-term outcome [ J ]. Circulation, 1999,100 ( 18 ) : 1872 - 1878.
4Mach F. Toward new therapeutic strategies against neointimal formation in restenosis[ J ]. Atheroseler Thmmb Vase B iol, 2000,20 ( 7 ) : 1699 - 1700.
5inoue K, Cynshi O, Kawabe Y, et al. Effect of BO-653 and probucol on c-MYC and PDGF-A messenger RNA of the iliacartery after balloon de- nudation in cholesterol-fed rabbits [ J ]. Athemsclerosis, 2002,161 ( 2 ) : 353 - 363.
6Waller BF, Pinkeerton CA, Orr CM, et al. Morphological observations late greater than 30 days after clinically successful coronary balloon an- gioplasty [ J ]. Circulation, 1991,83 [ 2 Suppl ] : 28 - 41.
7Gibbons GH. Dzau VJ. The emerging concept of vascular remodeling [J].N Eng J Med,1994,330(20) :1431 - 1438.
8Glagov S, Weisenberg E, Zarins CK, et al. Compensatory enlargement of human atheroselerotic coronary afleries [ J]. N Eng J Med, 1987,316 (22) :1371 - 1375.
9Lafont A, Durand E, Samuel JL, et al. Endothelial dysfunction and colla- gen accumulation:two independent factors for restenosis and constrictive remodeling after experimental angioplasty [ J ]. Circulation, 1999, 100 (10) :1109 -1115.
10Suzumura H, Hosokawa H, Suzuki T, et al. Comparison Of dilatation mechanism and long-term vessel remodeling between directional coro- nary atherectomy and balloon angioplasty assessed by volumetric intra- vaseular ultrasound [ J ]. J lnvasive Cardiol, 2002,14 ( 6 ) : 315 - 320.
二级参考文献15
1Regar E, Sianos G, Serruys P W. Stent development and local drug delivery[J]. Br Med Bull, 2001,59 : 227-248.
2Rossouw J E. Lipid lowering interventions in angiographic trials [J]. Am J Cardiol,1995,76:86C -92C.
3Martin G, Duez H, Blanquart C, Berezowski V, Poulain P, Fruchart J C, et al. Statin-induced inhibition of the Rho-signaling pathway activates PPARalpha and induces HDL apoA I[J]. J Clin Invest, 2001,107 : 1423- 1432.
4Davidson M,Ma P,Stein E A,Gotto A M Jr,Raza A,Chitra R, et al. Comparison of effects on low-density lipoprotein choles terol and high-density lipoprotein cholesterol with rosuvastatin versus atorvastatin in patients with type Ⅱ a or Ⅱ b hypercholesterolemia[J]. Am J Cardiol, 2002,89 : 268-275.
5Ridker P M,Danielson E,Fonseca F A,Genest J,Gotto A M Jr, Kastelein J J, et al. Rosuvastatin to prevent vascular events in men and women with elevated C reactive protein[J]. N Engl J Med, 2008,359 : 2195-2207.
6Serruys PW, de Jaegere P, Kiemeneij E, et al. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease ; Benestent StudyGroup[J]. N Eng J Med, 1994,331:489-4995.
7Alfonso F,Cequier A,Zueco J,et al. Stenting the stent: Initial results and long-term cilinical and angiographic outcome of coronary stenting for patients with in-stent restenosis[J]. Am J Cardiol, 2000,85:327-332.
8Mehran R,Dangas G,Abizaid A,et al. Angiographic patterns of in-stent restenosis classification and implications for longterm outcome[J]. Circulation, 1999,100 : 1872-1878.
9Faxon DP. Predicting restenosis: Bigger Is Better but Not Best[J]. Circulation, 2000,101 :946-947.
10Goldberg SL, Loussararian A, Gregorio J, et al. Predictors of diffuse and aggressive intra-stent restenosis [J]. J Am Coll Cardiol, 2001,37:1019-1025.
